Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 19, 2019 - Issue 10: Biosimilars
Submit an article Journal homepage
337
Views
5
CrossRef citations to date
0
Altmetric
Review

Bioequivalence studies with anti-TNF biosimilars

Mercedes Gimeno-GraciaService of Pharmacy, Hospital Clínico Universitario “Lozano Blesa”, IIS Aragón, Zaragoza, SpainView further author information
,
Carla J. Gargallo-PuyueloDigestive Diseases Service, Hospital Clínico Universitario “Lozano Blesa”, IIS Aragón, CIBEREHD, Zaragoza, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3545-2707View further author information
ORCID Icon &
Fernando GomollónDepartamento de Medicina, Facultad de Medicina, Digestive Diseases Service, Hospital Clínico Universitario “Lozano Blesa”, IIS Aragón, CIBEREHD, Zaragoza, SpainView further author information
Pages 1031-1043 | Received 11 Sep 2018, Accepted 17 Dec 2018, Published online: 31 Dec 2018

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Fabrizio Cantini, Delia Goletti, Maurizio Benucci, Rosario Foti, Arianna Damiani & Laura Niccoli. (2022) Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements. Expert Opinion on Drug Safety 21:5, pages 613-623.
Read now

Articles from other publishers (4)

Lennart Ocker, Nessr Abu Rached, Caroline Seifert, Christina Scheel & Falk G. Bechara. (2022) Current Medical and Surgical Treatment of Hidradenitis Suppurativa—A Comprehensive Review. Journal of Clinical Medicine 11:23, pages 7240.
Crossref
Hugo Jourdain, Léa Hoisnard, Emilie Sbidian & Mahmoud Zureik. (2022) TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System. Scientific Reports 12:1.
Crossref
Martina Burlando, Gabriella Fabbrocini, Claudio Marasca, Paolo Dapavo, Andrea Chiricozzi, Dalma Malvaso, Valentina Dini, Anna Campanati, Annamaria Offidani, Annunziata Dattola, Raffaele Dante Caposiena Caro, Luca Bianchi, Marina Venturini, Paolo Gisondi, Claudio Guarneri, Giovanna Malara, Caterina Trifirò, Piergiorigio Malagoli, Maria Concetta Fargnoli, Stefano Piaserico, Luca Carmisciano, Riccardo Castelli & Aurora Parodi. (2022) Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study. Biomedicines 10:10, pages 2522.
Crossref
Ulrich Mrowietz. (2020) Biosimilars für Psoriasis und Psoriasis-Arthritis. hautnah dermatologie 36:S1, pages 24-25.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.